These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 722483)

  • 41. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anion-exchange resins in pseudomembranous colitis.
    George RH; Youngs DJ; Johnson EM; Burdon DW
    Lancet; 1978 Sep; 2(8090):624. PubMed ID: 80541
    [No Abstract]   [Full Text] [Related]  

  • 43. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment].
    Richter WO
    Fortschr Med; 1996 May; 114(14):177-8. PubMed ID: 8707237
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ; Tsang RC; Fallat RW; Mellies M
    Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urethral calculi caused by cholestyramine.
    Courtney SP; Wightman JA
    Br J Urol; 1991 Dec; 68(6):654. PubMed ID: 1773297
    [No Abstract]   [Full Text] [Related]  

  • 46. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Lipid Research Clinics Coronary Primary Prevention Trial.
    Rifkind BM
    Drugs; 1986; 31 Suppl 1():53-60. PubMed ID: 3720571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypercholesteremia. Treatment with cholestyramine, a bile acid sequestering resin.
    Casdorph HR
    Calif Med; 1967 Apr; 106(4):293-5. PubMed ID: 4859983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acceptability of cholestyramine and colestipol formulations in three common vehicles.
    Ito MK; Morreale AP
    Clin Pharm; 1991 Feb; 10(2):138-40. PubMed ID: 2009732
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypercholesterolemia: new values, new strategies.
    Lueg MC; Anding RH
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):112-3, 116-7, 120-2. PubMed ID: 3080456
    [No Abstract]   [Full Text] [Related]  

  • 52. [Vasosan S--a cholestyramine in the treatment of hypercholesterolemia of various etiopathogenesis].
    Kolesár P
    Vnitr Lek; 1994 Feb; 40(2):89-92. PubMed ID: 8140767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
    Cattin L; Da Col PG; Fonda M; Mazzone C; Pertot P
    G Clin Med; 1990 Feb; 71(2):99-104. PubMed ID: 2347462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
    Farah JR; Kwiterovich PO; Neill CA
    Adv Exp Med Biol; 1977; 82():212-5. PubMed ID: 200092
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of six pharmacologic regimens for hypercholesterolemia.
    Hoeg JM; Maher MB; Bailey KR; Brewer HB
    Am J Cardiol; 1987 Apr; 59(8):812-5. PubMed ID: 3644588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term treatment of hypercholesterolemia with colestipol hydrochloride.
    Ryan JR; Jain AK; McMahon FG
    Clin Pharmacol Ther; 1975 Jan; 17(1):83-7. PubMed ID: 1091391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 58. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug management of hypercholesterolemia.
    Martz BL
    Am Heart J; 1979 Mar; 97(3):389-98. PubMed ID: 420081
    [No Abstract]   [Full Text] [Related]  

  • 60. Use and indications of cholestyramine and bile acid sequestrants.
    Scaldaferri F; Pizzoferrato M; Ponziani FR; Gasbarrini G; Gasbarrini A
    Intern Emerg Med; 2013 Apr; 8(3):205-10. PubMed ID: 21739227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.